Segment disclosures

Company overview

THERMOGENESIS CORP

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

69 dimension combinations 272 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Clinical Development

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31202000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence
2017-07-01 – 2017-12-31186000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence
2016-07-01 – 2017-06-30492000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Operating Segments · Device

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-319470000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence
2017-07-01 – 2017-12-315827000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence
2016-07-01 – 2017-06-3014033000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Operating Segments · Clinical Development

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3112957000 USD20200324Open filing evidence
2018-01-01 – 2018-12-319469000 USD20200324Open filing evidence

Operating Segments · Device

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3190000 USD20200324Open filing evidence
2018-01-01 – 2018-12-31203000 USD20200324Open filing evidence

Device Revenue · Clinical Development

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3138000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Revenue · Clinical Development · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3138000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Revenue · Device

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-317806000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Revenue · Device · Axp

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:AxpMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-314131000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Revenue · Device · Bioarchive

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:BioarchiveMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-311792000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Revenue · Device · CART Xpress

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:CARTXpressMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31907000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Revenue · Device · Manual Disposables

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:ManualDisposablesMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31976000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Other · Device

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=kool:OtherMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3195000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Other · Device · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=kool:OtherMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3195000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Revenue · Clinical Development

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3168000 USD20200324Open filing evidence
2018-01-01 – 2018-12-3138000 USD20200324Open filing evidence

Device Revenue · Clinical Development · Manual Disposables

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3168000 USD20200324Open filing evidence

Device Revenue · Clinical Development · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3138000 USD20200324Open filing evidence

Device Revenue · Device

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3111151000 USD20200324Open filing evidence
2018-01-01 – 2018-12-317806000 USD20200324Open filing evidence

Device Revenue · Device · Axp

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:AxpMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-314774000 USD20210317Open filing evidence
2020-07-01 – 2020-09-301137000 USD20201112Open filing evidence
2020-01-01 – 2020-09-304009000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30621000 USD20200814Open filing evidence
2020-01-01 – 2020-06-302829000 USD20200814Open filing evidence
2020-01-01 – 2020-03-312208000 USD20200515Open filing evidence
2019-01-01 – 2019-12-317313000 USD20210317Open filing evidence
2019-07-01 – 2019-09-302255000 USD20201112Open filing evidence
2019-01-01 – 2019-09-306550000 USD20201112Open filing evidence
2019-04-01 – 2019-06-303028000 USD20200814Open filing evidence
2019-01-01 – 2019-06-304295000 USD20200814Open filing evidence
2019-01-01 – 2019-03-311267000 USD20200515Open filing evidence
2018-01-01 – 2018-12-314131000 USD20200324Open filing evidence

Device Revenue · Device · Bioarchive

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:BioarchiveMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31855000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30337000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30675000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30165000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30329000 USD20200814Open filing evidence
2020-01-01 – 2020-03-31164000 USD20200515Open filing evidence
2019-01-01 – 2019-12-311472000 USD20210317Open filing evidence
2019-07-01 – 2019-09-30243000 USD20201112Open filing evidence
2019-01-01 – 2019-09-301274000 USD20201112Open filing evidence
2019-04-01 – 2019-06-30433000 USD20200814Open filing evidence
2019-01-01 – 2019-06-301031000 USD20200814Open filing evidence
2019-01-01 – 2019-03-31599000 USD20200515Open filing evidence
2018-01-01 – 2018-12-311792000 USD20200324Open filing evidence

Device Revenue · Device · CART Xpress

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-311471000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30332000 USD20201112Open filing evidence
2020-01-01 – 2020-09-301035000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30550000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30702000 USD20200814Open filing evidence
2020-01-01 – 2020-03-31152000 USD20200515Open filing evidence
2019-01-01 – 2019-12-311457000 USD20210317Open filing evidence
2019-07-01 – 2019-09-30875000 USD20201112Open filing evidence
2019-01-01 – 2019-09-301365000 USD20201112Open filing evidence
2019-04-01 – 2019-06-30182000 USD20200814Open filing evidence
2019-01-01 – 2019-06-30490000 USD20200814Open filing evidence
2019-01-01 – 2019-03-31307000 USD20200515Open filing evidence
2018-01-01 – 2018-12-31907000 USD20200324Open filing evidence

Device Revenue · Device · Manual Disposables

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31599000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30100000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30499000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30198000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30401000 USD20200814Open filing evidence
2020-01-01 – 2020-03-31203000 USD20200515Open filing evidence
2019-01-01 – 2019-12-31977000 RestatedUSD20210317Open filing evidence
2019-07-01 – 2019-09-30221000 USD20201112Open filing evidence
2019-01-01 – 2019-09-30764000 USD20201112Open filing evidence
2019-04-01 – 2019-06-30242000 USD20200814Open filing evidence
2019-01-01 – 2019-06-30543000 USD20200814Open filing evidence
2019-01-01 – 2019-03-31300000 USD20200515Open filing evidence
2018-01-01 – 2018-12-31976000 USD20200324Open filing evidence

Device Revenue · Device · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31289000 USD20210317Open filing evidence
2020-07-01 – 2020-09-3026000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30276000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30238000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30252000 USD20200814Open filing evidence
2020-01-01 – 2020-03-3114000 USD20200515Open filing evidence
2019-01-01 – 2019-09-305000 USD20201112Open filing evidence
2019-01-01 – 2019-06-305000 USD20200814Open filing evidence
2019-01-01 – 2019-03-315000 USD20200515Open filing evidence

Other · Device

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=thmo:OtherMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-31146000 USD20200324Open filing evidence
2018-01-01 – 2018-12-3195000 USD20200324Open filing evidence

Other · Device · CART Xpress

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:OtherMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31286000 USD20210317Open filing evidence
2020-07-01 – 2020-09-3071000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30214000 USD20201112Open filing evidence
2020-04-01 – 2020-06-3071000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30142000 USD20200814Open filing evidence
2020-01-01 – 2020-03-3171000 USD20200515Open filing evidence
2019-01-01 – 2019-12-3195000 USD20210317Open filing evidence
2019-07-01 – 2019-09-3033000 USD20201112Open filing evidence
2019-01-01 – 2019-09-3033000 USD20201112Open filing evidence

Other · Device · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=thmo:OtherMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-3162000 USD20210317Open filing evidence
2020-07-01 – 2020-09-3016000 USD20201112Open filing evidence
2020-01-01 – 2020-09-3039000 USD20201112Open filing evidence
2020-04-01 – 2020-06-3044000 USD20200814Open filing evidence
2020-01-01 – 2020-06-3064000 USD20200814Open filing evidence
2020-01-01 – 2020-03-3120000 USD20200515Open filing evidence
2019-01-01 – 2019-12-3151000 USD20210317Open filing evidence
2019-07-01 – 2019-09-3019000 USD20201112Open filing evidence
2019-01-01 – 2019-09-3040000 USD20201112Open filing evidence
2019-04-01 – 2019-06-308000 USD20200814Open filing evidence
2019-01-01 – 2019-06-3022000 USD20200814Open filing evidence
2019-01-01 – 2019-03-3114000 USD20200515Open filing evidence
2018-01-01 – 2018-12-3195000 USD20200324Open filing evidence

Service · Clinical Development

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31165000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Service · Clinical Development · Bone Marrow

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:BoneMarrowMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31135000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Service · Clinical Development · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3130000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Service · Device

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-311568000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Service · Device · Axp

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:AxpMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31262000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Service · Device · Bioarchive

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:BioarchiveMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-311306000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Service · Clinical Development

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3122000 USD20200324Open filing evidence
2018-01-01 – 2018-12-31165000 USD20200324Open filing evidence

Service · Clinical Development · Bone Marrow

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:BoneMarrowMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31135000 USD20200324Open filing evidence

Service · Clinical Development · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3122000 USD20200324Open filing evidence
2018-01-01 – 2018-12-3130000 USD20200324Open filing evidence

Service · Device

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-311660000 USD20200324Open filing evidence
2018-01-01 – 2018-12-311568000 USD20200324Open filing evidence

Service · Device · Axp

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:AxpMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31160000 USD20210317Open filing evidence
2020-07-01 – 2020-09-3032000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30103000 USD20201112Open filing evidence
2020-04-01 – 2020-06-3048000 USD20200814Open filing evidence
2020-01-01 – 2020-06-3072000 USD20200814Open filing evidence
2020-01-01 – 2020-03-3124000 USD20200515Open filing evidence
2019-01-01 – 2019-12-31209000 USD20210317Open filing evidence
2019-07-01 – 2019-09-3051000 USD20201112Open filing evidence
2019-01-01 – 2019-09-30160000 USD20201112Open filing evidence
2019-04-01 – 2019-06-3054000 USD20200814Open filing evidence
2019-01-01 – 2019-06-30109000 USD20200814Open filing evidence
2019-01-01 – 2019-03-3155000 USD20200515Open filing evidence
2018-01-01 – 2018-12-31262000 USD20200324Open filing evidence

Service · Device · Bioarchive

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:BioarchiveMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-311177000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30282000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30900000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30294000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30626000 USD20200814Open filing evidence
2020-01-01 – 2020-03-31332000 USD20200515Open filing evidence
2019-01-01 – 2019-12-311438000 USD20210317Open filing evidence
2019-07-01 – 2019-09-30351000 USD20201112Open filing evidence
2019-01-01 – 2019-09-301117000 USD20201112Open filing evidence
2019-04-01 – 2019-06-30351000 USD20200814Open filing evidence
2019-01-01 – 2019-06-30766000 USD20200814Open filing evidence
2019-01-01 – 2019-03-31415000 USD20200515Open filing evidence
2018-01-01 – 2018-12-311306000 USD20200324Open filing evidence

Service · Device · CART Xpress

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-3171000 USD20210317Open filing evidence
2020-07-01 – 2020-09-3022000 USD20201112Open filing evidence
2020-01-01 – 2020-09-3047000 USD20201112Open filing evidence
2020-04-01 – 2020-06-3013000 USD20200814Open filing evidence
2020-01-01 – 2020-06-3025000 USD20200814Open filing evidence
2020-01-01 – 2020-03-3112000 USD20200515Open filing evidence
2019-01-01 – 2019-12-3113000 USD20210317Open filing evidence
2019-07-01 – 2019-09-3010000 USD20201112Open filing evidence
2019-01-01 – 2019-09-306000 USD20201112Open filing evidence

Service · Device · Other Subsegments

Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3122000 RestatedUSD20210317Open filing evidence
2019-01-01 – 2019-09-3011000 USD20201112Open filing evidence
2019-04-01 – 2019-06-307000 USD20200814Open filing evidence
2019-01-01 – 2019-06-307000 USD20200814Open filing evidence

Product Concentration Risk · Axp

Concentration Risk By Type · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:AxpMember
PeriodValueUnitFiledEvidence
2016-07-01 – 2017-06-308715000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2015-07-01 – 2016-06-306932000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2014-07-01 – 2015-06-306612000 USD20160921Open filing evidence
2013-07-01 – 2014-06-306143000 USD20150917Open filing evidence

Product Concentration Risk · Bioarchive

Concentration Risk By Type · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:BioarchiveMember
PeriodValueUnitFiledEvidence
2016-07-01 – 2017-06-303318000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2015-07-01 – 2016-06-302465000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2014-07-01 – 2015-06-304241000 USD20160921Open filing evidence
2013-07-01 – 2014-06-304776000 USD20150917Open filing evidence

Product Concentration Risk · Bone Marrow

Concentration Risk By Type · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:BoneMarrowMember
PeriodValueUnitFiledEvidence
2016-07-01 – 2017-06-30745000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2015-07-01 – 2016-06-30459000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2014-07-01 – 2015-06-302621000 USD20160921Open filing evidence
2013-07-01 – 2014-06-302542000 USD20150917Open filing evidence

Product Concentration Risk · Manual Disposables

Concentration Risk By Type · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:ManualDisposablesMember
PeriodValueUnitFiledEvidence
2016-07-01 – 2017-06-301195000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2015-07-01 – 2016-06-301507000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2014-07-01 – 2015-06-301810000 USD20160921Open filing evidence
2013-07-01 – 2014-06-301706000 USD20150917Open filing evidence

Product Concentration Risk · All Other Segments

Concentration Risk By Type · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2016-07-01 – 2017-06-30552000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2015-07-01 – 2016-06-30566000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence
2014-07-01 – 2015-06-30758000 USD20160921Open filing evidence
2013-07-01 – 2014-06-30820000 USD20150917Open filing evidence

Operating Segments · Clinical Development

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2017-07-01 – 2017-09-30126000 USD2017-11-14 · 21:41:47.000ZOpen filing evidence

Operating Segments · Clinical Protocols

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalProtocolsMember
PeriodValueUnitFiledEvidence
2016-07-01 – 2016-09-30156000 USD2017-11-14 · 21:41:47.000ZOpen filing evidence

Operating Segments · Device

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember
PeriodValueUnitFiledEvidence
2017-07-01 – 2017-09-302943000 USD2017-11-14 · 21:41:47.000ZOpen filing evidence

Operating Segments · Device Registration

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceRegistrationMember
PeriodValueUnitFiledEvidence
2016-07-01 – 2016-09-303611000 USD2017-11-14 · 21:41:47.000ZOpen filing evidence

Clinical Development

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31203000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence
2016-07-01 – 2017-06-30492000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence

Clinical Development · Bone Marrow

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:BoneMarrowMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31135000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Clinical Development · Other Subsegments

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3168000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Clinical Protocols

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalProtocolsMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2016-06-30646000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence

Device

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-319469000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence
2016-07-01 – 2017-06-3014033000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence

Device · Axp

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:AxpMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-314393000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device · Bioarchive

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:BioarchiveMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-313098000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device · CART Xpress

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:CARTXpressMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31907000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device · Manual Disposables

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:ManualDisposablesMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31976000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device · Other Subsegments

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-3195000 USD2019-03-26 · 18:16:55.000ZOpen filing evidence

Device Registration

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=kool:DeviceRegistrationMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2016-06-3011283000 USD2017-09-22 · 00:05:37.000ZOpen filing evidence

Clinical Development

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3190000 USD20200324Open filing evidence
2018-01-01 – 2018-12-31203000 USD20200324Open filing evidence

Clinical Development · Bone Marrow

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:BoneMarrowMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31135000 USD20200324Open filing evidence

Clinical Development · Manual Disposables

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3168000 USD20200324Open filing evidence

Clinical Development · Other Subsegments

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3122000 USD20200324Open filing evidence
2018-01-01 – 2018-12-3168000 USD20200324Open filing evidence

Device

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3112957000 USD20200324Open filing evidence
2018-01-01 – 2018-12-319469000 USD20200324Open filing evidence

Device · Axp

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:AxpMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-314934000 USD20210317Open filing evidence
2020-07-01 – 2020-09-301169000 USD20201112Open filing evidence
2020-01-01 – 2020-09-304112000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30669000 USD20200814Open filing evidence
2020-01-01 – 2020-06-302901000 USD20200814Open filing evidence
2020-01-01 – 2020-03-312232000 USD20200515Open filing evidence
2019-01-01 – 2019-12-317522000 USD20210317Open filing evidence
2019-07-01 – 2019-09-302306000 USD20201112Open filing evidence
2019-01-01 – 2019-09-306710000 USD20201112Open filing evidence
2019-04-01 – 2019-06-303082000 USD20200814Open filing evidence
2019-01-01 – 2019-06-304404000 USD20200814Open filing evidence
2019-01-01 – 2019-03-311322000 USD20200515Open filing evidence
2018-01-01 – 2018-12-314393000 USD20200324Open filing evidence

Device · Bioarchive

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:BioarchiveMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-312032000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30619000 USD20201112Open filing evidence
2020-01-01 – 2020-09-301575000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30459000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30955000 USD20200814Open filing evidence
2020-01-01 – 2020-03-31496000 USD20200515Open filing evidence
2019-01-01 – 2019-12-312910000 USD20210317Open filing evidence
2019-07-01 – 2019-09-30594000 USD20201112Open filing evidence
2019-01-01 – 2019-09-302391000 USD20201112Open filing evidence
2019-04-01 – 2019-06-30784000 USD20200814Open filing evidence
2019-01-01 – 2019-06-301797000 USD20200814Open filing evidence
2019-01-01 – 2019-03-311014000 USD20200515Open filing evidence
2018-01-01 – 2018-12-313098000 USD20200324Open filing evidence

Device · CART Xpress

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-311828000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30425000 USD20201112Open filing evidence
2020-01-01 – 2020-09-301296000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30634000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30869000 USD20200814Open filing evidence
2020-01-01 – 2020-03-31235000 USD20200515Open filing evidence
2019-01-01 – 2019-12-311565000 USD20210317Open filing evidence
2019-07-01 – 2019-09-30918000 USD20201112Open filing evidence
2019-01-01 – 2019-09-301404000 USD20201112Open filing evidence
2019-04-01 – 2019-06-30182000 USD20200814Open filing evidence
2019-01-01 – 2019-06-30490000 USD20200814Open filing evidence
2019-01-01 – 2019-03-31307000 USD20200515Open filing evidence
2018-01-01 – 2018-12-31907000 USD20200324Open filing evidence

Device · Manual Disposables

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31599000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30100000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30499000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30198000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30401000 USD20200814Open filing evidence
2020-01-01 – 2020-03-31203000 USD20200515Open filing evidence
2019-01-01 – 2019-12-31977000 RestatedUSD20210317Open filing evidence
2019-07-01 – 2019-09-30221000 USD20201112Open filing evidence
2019-01-01 – 2019-09-30764000 USD20201112Open filing evidence
2019-04-01 – 2019-06-30242000 USD20200814Open filing evidence
2019-01-01 – 2019-06-30543000 USD20200814Open filing evidence
2019-01-01 – 2019-03-31300000 USD20200515Open filing evidence
2018-01-01 – 2018-12-31976000 USD20200324Open filing evidence

Device · Other Subsegments

Statement Business Segments · Subsegments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31351000 USD20210317Open filing evidence
2020-07-01 – 2020-09-3042000 USD20201112Open filing evidence
2020-01-01 – 2020-09-30315000 USD20201112Open filing evidence
2020-04-01 – 2020-06-30282000 USD20200814Open filing evidence
2020-01-01 – 2020-06-30316000 USD20200814Open filing evidence
2020-01-01 – 2020-03-3134000 USD20200515Open filing evidence
2019-01-01 – 2019-12-3173000 RestatedUSD20210317Open filing evidence
2019-07-01 – 2019-09-3019000 USD20201112Open filing evidence
2019-01-01 – 2019-09-3056000 USD20201112Open filing evidence
2019-04-01 – 2019-06-3015000 USD20200814Open filing evidence
2019-01-01 – 2019-06-3034000 USD20200814Open filing evidence
2019-01-01 – 2019-03-3119000 USD20200515Open filing evidence
2018-01-01 – 2018-12-3195000 USD20200324Open filing evidence